Key Insights
The global exoskeleton market is experiencing robust growth, projected to reach a significant size by 2033. A compound annual growth rate (CAGR) of 12.50% from 2025 to 2033 indicates a substantial increase in market value over the forecast period. This expansion is driven by several factors, including the increasing prevalence of neurological disorders and spinal cord injuries necessitating rehabilitation solutions, the rising demand for assistive devices in healthcare and industrial settings, and advancements in robotics and sensor technologies leading to more sophisticated and user-friendly exoskeletons. Furthermore, the growing elderly population globally, along with the increasing focus on workplace safety and productivity, are fueling the adoption of exoskeletons for both therapeutic and industrial applications. The market is segmented by treatment type (rehabilitation and augmentation), body part type (upper and lower body), and product type (stationary and mobile), offering diverse options tailored to specific needs. North America currently holds a significant market share, driven by high technological advancements and robust healthcare infrastructure. However, the Asia-Pacific region is expected to witness significant growth owing to its large and rapidly aging population, increasing healthcare spending, and rising awareness of exoskeleton technology. While the high cost of exoskeletons and potential regulatory hurdles represent some constraints, the overall market trajectory points towards a positive and expanding future.
The competitive landscape includes established players like Parker-Hannifin Corp and Ekso Bionics Holdings, along with emerging companies like B-Temia Inc and Rewalk Robotics, constantly innovating to improve functionality, affordability, and user experience. The market is witnessing the integration of advanced materials, artificial intelligence, and machine learning to enhance the performance and adaptability of exoskeletons. Further developments in areas like battery technology and human-machine interfaces are poised to further propel market growth. The segmentation by treatment type, body part, and product type allows companies to focus on specific niches and tailor their offerings to the varying needs of patients and industrial users. Regional variations in market penetration will likely continue, with developed nations leading in adoption rates while developing economies witness increasing demand as healthcare infrastructure and awareness improve. The long-term outlook for the exoskeleton market remains strongly positive, fueled by continuous technological advancements and growing global demand.

Exoskeleton Industry Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the global exoskeleton industry, offering actionable insights for stakeholders across the value chain. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report projects a market exceeding xx Million by 2033, exhibiting a CAGR of xx% during the forecast period. Key players like Parker-Hannifin Corp, B-Temia Inc, and Ekso Bionics Holdings are analyzed, alongside emerging opportunities and challenges within the rehabilitation, augmentation, upper body, and lower body exoskeleton segments.
Exoskeleton Industry Market Concentration & Dynamics
The global exoskeleton market is characterized by moderate concentration, with a handful of major players holding significant market share. Parker-Hannifin Corp, Ekso Bionics Holdings, and Rewalk Robotics currently account for an estimated xx% of the market (2025). The industry is witnessing rapid innovation, driven by advancements in robotics, sensors, and artificial intelligence. Regulatory frameworks vary across geographies, impacting market entry and product adoption. Substitute products, such as traditional physical therapy methods, pose a competitive challenge, although the unique benefits of exoskeletons are steadily gaining traction. End-user trends favor personalized solutions and improved user interfaces, prompting companies to invest in advanced technologies and data analytics.
M&A activity has been moderate over the past five years, with approximately xx deals reported between 2019 and 2024. These mergers and acquisitions primarily focused on strengthening technological capabilities and expanding market reach.
- Market Share (2025, Estimated): Parker-Hannifin Corp (xx%), Ekso Bionics Holdings (xx%), Rewalk Robotics (xx%), Others (xx%)
- M&A Deal Count (2019-2024): xx
- Key Innovation Areas: AI-powered control systems, advanced materials, miniaturization
Exoskeleton Industry Insights & Trends
The global exoskeleton market is experiencing robust growth, driven by a confluence of factors. The increasing prevalence of neurological disorders and musculoskeletal injuries, coupled with rising healthcare expenditures, is fueling demand for rehabilitation exoskeletons. Technological advancements, particularly in areas like lightweight materials, improved power sources, and intuitive control systems, are enhancing the functionality and user experience of exoskeletons, further driving market expansion. Consumer behavior is shifting towards greater acceptance and adoption of assistive technologies, fueled by increased awareness of the potential benefits of exoskeletons in improving mobility and quality of life. The market size in 2025 is estimated at xx Million, projected to reach xx Million by 2033.

Key Markets & Segments Leading Exoskeleton Industry
The North American market holds a dominant position in the global exoskeleton industry, primarily due to the high prevalence of neurological disorders and a strong regulatory framework supporting medical device innovation. Within the segments, the rehabilitation treatment type enjoys the highest market share, driven by the growing elderly population and increasing awareness of rehabilitation therapies. The lower body segment dominates the body part type category, reflecting a higher demand for mobility assistance solutions. Mobile exoskeletons are gaining popularity over stationary devices due to their versatility and improved user experience.
- Dominant Region: North America
- Dominant Treatment Type: Rehabilitation
- Dominant Body Part Type: Lower Body
- Dominant Product Type: Mobile
Drivers for North American Dominance:
- Strong healthcare infrastructure and investment in medical technologies
- High prevalence of age-related diseases requiring rehabilitation
- Favorable regulatory environment for medical device approvals
Exoskeleton Industry Product Developments
Recent product innovations include the introduction of lighter, more comfortable exoskeletons with advanced control systems. These advancements are enhancing user experience and broadening the range of applications, including use in industrial settings for enhanced strength and endurance. Companies are increasingly integrating AI and machine learning algorithms for more personalized and adaptive support, improving treatment outcomes and expanding the market potential.
Challenges in the Exoskeleton Industry Market
The exoskeleton industry faces challenges such as stringent regulatory approvals, complex supply chains, and high manufacturing costs. Regulatory hurdles vary across different geographies, creating market entry barriers for new players. Supply chain disruptions, especially concerning specialized components, can lead to production delays and increased costs. Intense competition among established players and new entrants also poses a challenge. The impact of these challenges, measured in delayed product launches and reduced profit margins, is estimated to be xx Million annually.
Forces Driving Exoskeleton Industry Growth
Key growth drivers include technological advancements, increasing healthcare spending, and growing demand for rehabilitation solutions. Miniaturization of components, the development of more comfortable and adaptable devices, and the use of AI in control systems are driving wider adoption. Government initiatives to support assistive technologies, combined with rising healthcare budgets, are boosting market growth. Regulatory approvals for new applications, such as industrial use, are also contributing to market expansion.
Long-Term Growth Catalysts in the Exoskeleton Industry
Long-term growth will be driven by continued technological innovations, strategic partnerships between technology companies and healthcare providers, and expansion into new markets. The development of more affordable and accessible exoskeletons will broaden market penetration. Collaborative efforts to develop integrated solutions across various healthcare settings will accelerate adoption. Exploring new applications, such as industrial assistance and military uses, will unlock significant growth opportunities.
Emerging Opportunities in Exoskeleton Industry
Emerging opportunities lie in the development of specialized exoskeletons for specific needs (e.g., stroke rehabilitation, post-surgical recovery), integration with virtual reality for immersive rehabilitation, and expansion into developing markets with growing healthcare needs. The increasing adoption of telemedicine and remote monitoring capabilities also presents exciting opportunities. Personalized exoskeleton design based on individual user data offers significant potential for market growth.
Leading Players in the Exoskeleton Industry Sector
- Parker-Hannifin Corp
- B-Temia Inc
- Rewalk Robotics
- Rehab-Robotics Company Limited
- Gogoa Mobility Robots
- Bioservo Technologies AB
- Bionik Laboratories Corp
- Cyberdyne Inc
- Ekso Bionics Holdings
- Bioness Inc
Key Milestones in Exoskeleton Industry Industry
- 2020: FDA approves a new exoskeleton for stroke rehabilitation.
- 2021: Major partnership between a tech company and a hospital system to integrate exoskeletons into rehabilitation programs.
- 2022: Launch of a new lightweight exoskeleton for industrial applications.
- 2023: Acquisition of a smaller exoskeleton company by a larger medical device manufacturer.
- 2024: Several new exoskeletons receive CE marking for European distribution.
Strategic Outlook for Exoskeleton Industry Market
The exoskeleton industry is poised for significant growth in the coming years. Technological advancements, expanding applications, and strategic partnerships will drive market expansion. Focusing on personalized solutions, improved user experiences, and expanding into emerging markets will be crucial for achieving long-term success. Companies that can effectively navigate the regulatory landscape and address supply chain challenges will be best positioned to capitalize on the significant market opportunities.
Exoskeleton Industry Segmentation
-
1. Treatment Type
- 1.1. Rehabilitation
- 1.2. Augmentation
-
2. Body Part Type
- 2.1. Upper Body
- 2.2. Lower Body
-
3. Product Type
- 3.1. Stationary
- 3.2. Mobile
Exoskeleton Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America

Exoskeleton Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 12.50% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Demand from Healthcare Sector for Robotic Rehabilitation; Advancement in Robotic Technologies; Huge Investment for the Development of the Exoskeleton Technology
- 3.3. Market Restrains
- 3.3.1. Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines
- 3.4. Market Trends
- 3.4.1. The Mobile Segment is Expected to Hold the Largest Share by Product Type Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 5.1.1. Rehabilitation
- 5.1.2. Augmentation
- 5.2. Market Analysis, Insights and Forecast - by Body Part Type
- 5.2.1. Upper Body
- 5.2.2. Lower Body
- 5.3. Market Analysis, Insights and Forecast - by Product Type
- 5.3.1. Stationary
- 5.3.2. Mobile
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6. North America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 6.1.1. Rehabilitation
- 6.1.2. Augmentation
- 6.2. Market Analysis, Insights and Forecast - by Body Part Type
- 6.2.1. Upper Body
- 6.2.2. Lower Body
- 6.3. Market Analysis, Insights and Forecast - by Product Type
- 6.3.1. Stationary
- 6.3.2. Mobile
- 6.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7. Europe Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 7.1.1. Rehabilitation
- 7.1.2. Augmentation
- 7.2. Market Analysis, Insights and Forecast - by Body Part Type
- 7.2.1. Upper Body
- 7.2.2. Lower Body
- 7.3. Market Analysis, Insights and Forecast - by Product Type
- 7.3.1. Stationary
- 7.3.2. Mobile
- 7.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8. Asia Pacific Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 8.1.1. Rehabilitation
- 8.1.2. Augmentation
- 8.2. Market Analysis, Insights and Forecast - by Body Part Type
- 8.2.1. Upper Body
- 8.2.2. Lower Body
- 8.3. Market Analysis, Insights and Forecast - by Product Type
- 8.3.1. Stationary
- 8.3.2. Mobile
- 8.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9. Middle East and Africa Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 9.1.1. Rehabilitation
- 9.1.2. Augmentation
- 9.2. Market Analysis, Insights and Forecast - by Body Part Type
- 9.2.1. Upper Body
- 9.2.2. Lower Body
- 9.3. Market Analysis, Insights and Forecast - by Product Type
- 9.3.1. Stationary
- 9.3.2. Mobile
- 9.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10. South America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 10.1.1. Rehabilitation
- 10.1.2. Augmentation
- 10.2. Market Analysis, Insights and Forecast - by Body Part Type
- 10.2.1. Upper Body
- 10.2.2. Lower Body
- 10.3. Market Analysis, Insights and Forecast - by Product Type
- 10.3.1. Stationary
- 10.3.2. Mobile
- 10.1. Market Analysis, Insights and Forecast - by Treatment Type
- 11. North America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 11.1.1 United States
- 11.1.2 Canada
- 11.1.3 Mexico
- 12. Europe Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 12.1.1 Germany
- 12.1.2 United Kingdom
- 12.1.3 France
- 12.1.4 Italy
- 12.1.5 Spain
- 12.1.6 Rest of Europe
- 13. Asia Pacific Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 13.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 13.1.1 China
- 13.1.2 Japan
- 13.1.3 India
- 13.1.4 Australia
- 13.1.5 South Korea
- 13.1.6 Rest of Asia Pacific
- 14. Middle East and Africa Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 14.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 14.1.1 GCC
- 14.1.2 South Africa
- 14.1.3 Rest of Middle East and Africa
- 15. South America Exoskeleton Industry Analysis, Insights and Forecast, 2019-2031
- 15.1. Market Analysis, Insights and Forecast - By Country/Sub-region
- 15.1.1 Brazil
- 15.1.2 Argentina
- 15.1.3 Rest of South America
- 16. Competitive Analysis
- 16.1. Global Market Share Analysis 2024
- 16.2. Company Profiles
- 16.2.1 Parker-Hannifin Corp
- 16.2.1.1. Overview
- 16.2.1.2. Products
- 16.2.1.3. SWOT Analysis
- 16.2.1.4. Recent Developments
- 16.2.1.5. Financials (Based on Availability)
- 16.2.2 B-Temia Inc
- 16.2.2.1. Overview
- 16.2.2.2. Products
- 16.2.2.3. SWOT Analysis
- 16.2.2.4. Recent Developments
- 16.2.2.5. Financials (Based on Availability)
- 16.2.3 Rewalk Robotics
- 16.2.3.1. Overview
- 16.2.3.2. Products
- 16.2.3.3. SWOT Analysis
- 16.2.3.4. Recent Developments
- 16.2.3.5. Financials (Based on Availability)
- 16.2.4 Rehab-Robotics Company Limited
- 16.2.4.1. Overview
- 16.2.4.2. Products
- 16.2.4.3. SWOT Analysis
- 16.2.4.4. Recent Developments
- 16.2.4.5. Financials (Based on Availability)
- 16.2.5 Gogoa Mobility Robots
- 16.2.5.1. Overview
- 16.2.5.2. Products
- 16.2.5.3. SWOT Analysis
- 16.2.5.4. Recent Developments
- 16.2.5.5. Financials (Based on Availability)
- 16.2.6 Bioservo Technologies AB
- 16.2.6.1. Overview
- 16.2.6.2. Products
- 16.2.6.3. SWOT Analysis
- 16.2.6.4. Recent Developments
- 16.2.6.5. Financials (Based on Availability)
- 16.2.7 Bionik Laboratories Corp
- 16.2.7.1. Overview
- 16.2.7.2. Products
- 16.2.7.3. SWOT Analysis
- 16.2.7.4. Recent Developments
- 16.2.7.5. Financials (Based on Availability)
- 16.2.8 Cyberdyne Inc
- 16.2.8.1. Overview
- 16.2.8.2. Products
- 16.2.8.3. SWOT Analysis
- 16.2.8.4. Recent Developments
- 16.2.8.5. Financials (Based on Availability)
- 16.2.9 Ekso Bionics Holdings
- 16.2.9.1. Overview
- 16.2.9.2. Products
- 16.2.9.3. SWOT Analysis
- 16.2.9.4. Recent Developments
- 16.2.9.5. Financials (Based on Availability)
- 16.2.10 Bioness Inc
- 16.2.10.1. Overview
- 16.2.10.2. Products
- 16.2.10.3. SWOT Analysis
- 16.2.10.4. Recent Developments
- 16.2.10.5. Financials (Based on Availability)
- 16.2.1 Parker-Hannifin Corp
List of Figures
- Figure 1: Global Exoskeleton Industry Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: North America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 3: North America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 4: Europe Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 5: Europe Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 6: Asia Pacific Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 7: Asia Pacific Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 8: Middle East and Africa Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 9: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 10: South America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 11: South America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 12: North America Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 13: North America Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 14: North America Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 15: North America Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 16: North America Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 17: North America Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 18: North America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 19: North America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 20: Europe Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 21: Europe Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 22: Europe Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 23: Europe Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 24: Europe Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 25: Europe Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 26: Europe Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 27: Europe Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 28: Asia Pacific Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 29: Asia Pacific Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 30: Asia Pacific Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 31: Asia Pacific Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 32: Asia Pacific Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 33: Asia Pacific Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 34: Asia Pacific Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 35: Asia Pacific Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 36: Middle East and Africa Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 37: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 38: Middle East and Africa Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 39: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 40: Middle East and Africa Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 41: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 42: Middle East and Africa Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 43: Middle East and Africa Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
- Figure 44: South America Exoskeleton Industry Revenue (Million), by Treatment Type 2024 & 2032
- Figure 45: South America Exoskeleton Industry Revenue Share (%), by Treatment Type 2024 & 2032
- Figure 46: South America Exoskeleton Industry Revenue (Million), by Body Part Type 2024 & 2032
- Figure 47: South America Exoskeleton Industry Revenue Share (%), by Body Part Type 2024 & 2032
- Figure 48: South America Exoskeleton Industry Revenue (Million), by Product Type 2024 & 2032
- Figure 49: South America Exoskeleton Industry Revenue Share (%), by Product Type 2024 & 2032
- Figure 50: South America Exoskeleton Industry Revenue (Million), by Country 2024 & 2032
- Figure 51: South America Exoskeleton Industry Revenue Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Exoskeleton Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 3: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 4: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 5: Global Exoskeleton Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 6: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 7: United States Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Canada Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: Mexico Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 11: Germany Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: United Kingdom Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: France Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: Italy Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 15: Spain Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Rest of Europe Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 18: China Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Japan Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: India Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Australia Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: South Korea Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Rest of Asia Pacific Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 25: GCC Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: South Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 27: Rest of Middle East and Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 29: Brazil Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: Argentina Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 31: Rest of South America Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 33: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 34: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 35: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 36: United States Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 37: Canada Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Mexico Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 39: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 40: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 41: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 42: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 43: Germany Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: United Kingdom Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 45: France Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: Italy Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 47: Spain Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: Rest of Europe Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 49: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 50: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 51: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 52: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 53: China Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: Japan Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 55: India Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Australia Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 57: South Korea Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: Rest of Asia Pacific Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 59: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 60: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 61: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 62: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 63: GCC Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: South Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 65: Rest of Middle East and Africa Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 66: Global Exoskeleton Industry Revenue Million Forecast, by Treatment Type 2019 & 2032
- Table 67: Global Exoskeleton Industry Revenue Million Forecast, by Body Part Type 2019 & 2032
- Table 68: Global Exoskeleton Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 69: Global Exoskeleton Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 70: Brazil Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 71: Argentina Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 72: Rest of South America Exoskeleton Industry Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Exoskeleton Industry?
The projected CAGR is approximately 12.50%.
2. Which companies are prominent players in the Exoskeleton Industry?
Key companies in the market include Parker-Hannifin Corp, B-Temia Inc, Rewalk Robotics, Rehab-Robotics Company Limited, Gogoa Mobility Robots, Bioservo Technologies AB, Bionik Laboratories Corp, Cyberdyne Inc, Ekso Bionics Holdings, Bioness Inc.
3. What are the main segments of the Exoskeleton Industry?
The market segments include Treatment Type, Body Part Type, Product Type.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Growing Demand from Healthcare Sector for Robotic Rehabilitation; Advancement in Robotic Technologies; Huge Investment for the Development of the Exoskeleton Technology.
6. What are the notable trends driving market growth?
The Mobile Segment is Expected to Hold the Largest Share by Product Type Over the Forecast Period.
7. Are there any restraints impacting market growth?
Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines.
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Exoskeleton Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Exoskeleton Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Exoskeleton Industry?
To stay informed about further developments, trends, and reports in the Exoskeleton Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence